NCT03516305View on ClinicalTrials.gov

Pharmacokinetic Study Evaluating Staccato® Alprazolam 1 mg Inhaler in Smokers Versus Non-Smokers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 6, 2018

Primary Completion Date

August 1, 2018

Study Completion Date

August 1, 2018

Conditions
Healthy
Interventions
DRUG

Staccato Alprazolam 1 mg

alprazolam I mg administered via the Staccato hand-held inhaler device system.

Trial Locations (1)

07724

Clinilabs Research Unit, Eatontown

Sponsors

Collaborators (1)

Clinilabs, Inc.
All Listed Sponsors
collaborator

Clinilabs, Inc.

OTHER

lead

Engage Therapeutics, Inc.

INDUSTRY

NCT03516305 - Pharmacokinetic Study Evaluating Staccato® Alprazolam 1 mg Inhaler in Smokers Versus Non-Smokers | Biotech Hunter | Biotech Hunter